Ameritas Investment Partners, Inc. - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 122 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,038
-30.3%
1,973
+33.6%
0.00%0.0%
Q2 2023$31,608
-47.1%
1,4770.0%0.00%
-50.0%
Q1 2023$59,730
-18.4%
1,4770.0%0.00%
-33.3%
Q4 2022$73,171
-3.7%
1,4770.0%0.00%0.0%
Q3 2022$76,000
+10.1%
1,4770.0%0.00%0.0%
Q2 2022$69,000
-34.3%
1,4770.0%0.00%
-25.0%
Q1 2022$105,000
-4.5%
1,4770.0%0.00%0.0%
Q4 2021$110,000
+31.0%
1,4770.0%0.00%
+33.3%
Q3 2021$84,000
+15.1%
1,477
-10.9%
0.00%0.0%
Q2 2021$73,000
-11.0%
1,6580.0%0.00%0.0%
Q1 2021$82,000
+17.1%
1,6580.0%0.00%0.0%
Q4 2020$70,000
-7.9%
1,6580.0%0.00%0.0%
Q3 2020$76,000
-8.4%
1,6580.0%0.00%
-25.0%
Q2 2020$83,000
+6.4%
1,658
+9.9%
0.00%0.0%
Q1 2020$78,000
-16.1%
1,5080.0%0.00%0.0%
Q4 2019$93,000
+10.7%
1,508
+8.1%
0.00%0.0%
Q3 2019$84,000
-28.8%
1,3950.0%0.00%
-20.0%
Q2 2019$118,000
-11.3%
1,3950.0%0.01%
-16.7%
Q1 2019$133,000
+34.3%
1,3950.0%0.01%
+20.0%
Q4 2018$99,000
-16.8%
1,3950.0%0.01%0.0%
Q3 2018$119,000
-22.2%
1,395
+5.7%
0.01%
-28.6%
Q2 2018$153,000
+53.0%
1,320
+6.9%
0.01%
+40.0%
Q1 2018$100,000
+38.9%
1,2350.0%0.01%
+66.7%
Q4 2017$72,000
+38.5%
1,2350.0%0.00%
+50.0%
Q3 2017$52,000
+18.2%
1,2350.0%0.00%0.0%
Q2 2017$44,000
+15.8%
1,2350.0%0.00%0.0%
Q1 2017$38,0001,2350.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders